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Ecologists distinguish between generalists and specialists on the basis 
of the width of an organism’s ecological niche1. In infectious diseases, 
the niche of a given pathogen is determined by host range and the 
agent’s capacity to survive in the environment2. Some microbes are 
obligate pathogens restricted to one or several host species3,4; others 
are mainly free living and are only occasionally pathogenic5. Little 
is known about the niche width of obligate human pathogens3. The 
causative agent of tuberculosis, known as the Mycobacterium tubercu-
losis complex (MTBC), is an obligate pathogen that comprises seven 
phylogenetic lineages adapted to humans and two lineages adapted 
to various wild and domestic animal species6. Some human-adapted 
MTBC lineages have received particular attention. For example, 
lineage 2, which includes the Beijing family of strains, has repeatedly 
been associated with drug resistance7. Lineage 2 likely originated in 
East Asia8,9 and has recently been expanding in some parts of the 
world10. By contrast, lineages 5 and 6 (also known as Mycobacterium 
africanum West Africa I and II) and lineage 7 are largely restricted 
to West and East Africa, respectively11,12. The observation that the 
human-adapted MTBC population is phylogeographically structured 
has led to the hypothesis that the different lineages might be adapted 
to particular human populations13. Support for this notion comes 
from the observation that sympatric host–pathogen associations in 
human tuberculosis remain stable over time, even in metropolitan set-
tings where host and pathogen populations intermix14–17. Moreover, 
sympatric host–pathogen associations are perturbed in patients co-
infected with HIV14, indicating that, in the context of reduced host 
immune competence, the different lineages can successfully infect and 
cause disease irrespective of the host genetic background.
Contrary to the other main human-adapted MTBC lineages, lineage 
4 exists at high frequencies on all inhabited continents18. It is hence 
geographically the most widespread cause of human tuberculo-
sis19. Yet, the reasons for this global success are unknown. Lineage 
4 has been shown to exhibit enhanced virulence in macrophage 
and animal models of infection, albeit with much variation among 
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geographically widespread cause of human tuberculosis. We show that lineage 4 comprises globally distributed and geographically 
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different lineage 4 strains19,20. Moreover, molecular epidemiological 
studies have reported considerable variation in the transmission 
success of different lineage 4 strains in clinical settings19. These 
observations suggest that lineage 4 is genetically and phenotypically 
diverse, and this diversity might determine the epidemiology of dif-
ferent lineage 4 subtypes in different parts of the world. The purpose 
of this study is to gain a better understanding of the global population 
structure of lineage 4 and the evolutionary forces that have contrib-
uted to the success of lineage 4 across the world. For this purpose, 
we combined large-scale SNP typing with targeted whole-genome 
sequencing of a global collection of lineage 4 clinical isolates.
RESULTS
MTBC lineage 4 comprises ten separate sublineages
We first analyzed 72 published genome sequences of lineage 4 clinical 
strains from global sources21,22. These strains harbored 9,455 variable 
single-nucleotide positions that divided lineage 4 into ten sublineages 
(L4.1.1 to L4.10 in Fig. 1a and Supplementary Fig. 1). We used four 
complementary approaches to validate these sublineages. First, we per-
formed principal-component analysis, which showed clear separation 
of seven sublineages (L4.1.1, L4.1.3, L4.1.2, L4.2, L4.3, L4.4 and L4.10; 
Supplementary Fig. 2). Sublineages L4.5, L4.6.1/Uganda and L4.6.2/
Cameroon were less clearly separated. Second, we found that the mean 
pairwise genetic distance between pairs of isolates within the subline-
ages was significantly lower than that between sublineages (276 SNPs 
versus 602 SNPs; Wilcoxon rank-sum test, P < 0.0001; Supplementary 
Fig. 3). Overall, the mean pairwise SNP distance between any two 
strains was 565 SNPs. Third, we calculated pairwise fixation indexes 
(FST) to evaluate the degree of population differentiation. All FST val-
ues between the sublineages were larger than 0.33 (Supplementary 
Table 1), indicating that these populations are separated. Fourth, we 
mapped previously reported phylogenetic markers onto our genome-
based phylogenetic tree15,23–28. Most of these markers were congruent 
with our sublineage definition (Supplementary Fig. 1).
Sublineages differ in their phylogeographical distributions
Because the MTBC exhibits limited sequence variation and little 
ongoing horizontal gene exchange, SNP homoplasies are extremely 
rare, making SNPs ideal phylogenetic markers29. We further scru-
tinized the 9,455 variable positions among the 72 MTBC lineage 4 
genomes and found 51 to 277 specific for one of each of the ten sub-
lineages. All of these variable positions were mutually exclusive: that 
is, they showed no homoplasy. We selected a subset of these subline-
age-specific SNPs and used them to screen a global collection of 3,366 
lineage 4 clinical isolates from 100 countries using various genotyp-
ing platforms30–35. First, we developed a novel sublineage-specific 
multiplexed SNP typing assay using the Luminex platform as previ-
ously reported36, and we used this method to screen 2,001 isolates 
(Supplementary Table 2). In addition, we screened 741 isolates using 
the Sequenom MassARRAY platform (Supplementary Table 3)37  
and 624 isolates by PCR and Sanger sequencing (Supplementary 
Table 4). Overall, 3,181 of 3,366 (94.5%) lineage 4 isolates were suc-
cessfully assigned to a sublineage (Supplementary Table 5). An 
additional 92 of 3,366 (2.7%) isolates harbored the reference allele 
for all sublineages, indicating that they belonged to one or several 
additional and unknown sublineages. For the remaining 93 of 3,366 
(2.8%) isolates, no classification could be obtained for various tech-
nical reasons. Among the 3,181 lineage 4 isolates assigned to one of 
the ten sublineages, L4.3/LAM was the most frequent, accounting for 
20.3%, followed by L4.6.1/Uganda (14.2%), L4.10/PGG3 (11.9%), L4.4 
(10.1%) and L4.1.2/Haarlem (9.9%) (Fig. 1b).
Mapping the proportion of each sublineage by country showed 
that the sublineages differed in their geographical distributions 
(Fig. 2). Specifically, L4.1.2/Haarlem, L4.3/LAM and L4.10/PGG3 
occurred globally (Fig. 3a and Supplementary Fig. 4). By contrast, 
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Figure 1 Definition and global frequency of lineage 4 sublineages.  
(a) We defined ten sublineages on the basis of the analysis of 72 MTBC 
lineage 4 genome sequences published previously21,22. Sublineages 
were labeled according to Coll et al.27 (whenever possible) and previous 
designations based on spoligotyping (supplementary Fig. 1). Black 
triangles represent sublineages identified as specialists, and black  
circles represent generalists. Filled shapes correspond to sublineages  
for which we performed deep genomic analyses. (b) Global proportion  
of each sublineage. A total of 3,366 MTBC lineage 4 isolates were 
screened for sublineage-specific SNPs. L4.3/LAM was the most frequent 
sublineage globally. ND, not defined.
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L4.1.3/Ghana, L4.5, L4.6.1/Uganda and L4.6.2/Cameroon occurred 
at high frequencies in specific regions of Africa or Asia, and were 
almost completely absent from Europe and the Americas (Fig. 3b). 
The geographical spread of the three remaining sublineages was inter-
mediate (Fig. 2 and Supplementary Figs. 4 and 5). L4.1.1/X mainly 
occurred in the Americas and in lower proportions in a few coun-
tries of southern Africa, Asia and Europe. L4.2 and L4.4 occurred in 
high proportions among isolates from particular countries in Asia 
and Africa, but were largely absent from the Americas (Fig. 2 and 
Supplementary Figs. 4 and 5). A similar pattern of sublineage distri-
bution was observed when normalizing by tuberculosis prevalence38 
and country surface area (Supplementary Fig. 6).
Populations that occupy a broader variety of environments may 
exhibit a wider geographical distribution. Humans differ in their 
susceptibility to tuberculosis39, and human genetic diversity may 
thus determine the width of the ecological niche accessible to differ-
ent MTBC genotypes40,41. The geographical restriction of particular 
MTBC genotypes might reflect local adaptation of these pathogen 
variants to the corresponding human host populations13,15. Such a 
sympatric host–pathogen association in human tuberculosis is com-
patible with the ‘local’ sublineages observed here and supports the 
notion that these sublineages represent ecological specialists. By con-
trast, the three ‘global’ sublineages could represent generalists capable 
of infecting and causing disease in many different human populations. 
This notion was supported by the fact that the three generalist sub-
lineages L4.1.2/Haarlem, L4.3/LAM and L4.10/PGG3 were observed 
in 49, 47 and 47 countries, respectively, whereas the specialist sub-
lineages L4.1.3/Ghana, L4.5, L4.6.1/Uganda and L4.6.2/Cameroon 
were only found in a few countries each (3, 7, 9 and 10 countries, 
respectively). The country frequencies of the remaining three sub-
lineages, L4.1/X, L4.2/Ural and L4.4, were intermediate (27, 14 and 
26 countries, respectively) (Supplementary Fig. 4).
The different geographical distributions of generalist and special-
ist sublineages could be due to intrinsic biological factors, extrinsic 
factors such as human migration, or both. Hence, we next performed 
various population genomic analyses to explore the genomic charac-
teristics of these lineage 4 generalists and specialists, as well as the 
role of human migration in the global spread of the most successful 
generalist sublineage.
Genomic features of generalist and specialist sublineages
The geographical and niche distributions of populations can be cor-
related with their genetic variability or with that of their ancestors. 
One possible reason for the restricted host range of the specialist 
sublineages might be historical; that is, the ancestor populations of 
the extant specialist populations may have harbored more deleteri-
ous mutations, restricting host range. To assess this possibility, we 
characterized the mutations that contributed to the divergence of the 
different sublineages; these mutations are variants that have become 
fixed during the evolution of the sublineages. We focused on substi-
tutions that occurred in all isolates of any of the generalist subline-
ages (L4.1.2/Haarlem, L4.3/LAM and L4.10/PGG3) and compared 
them to substitutions that occurred in all isolates of any of the three 
specialist sublineages (L4.6.1/Uganda, L4.5 and L4.6.2/Cameroon). 
We identified nonsynonymous SNPs predicted to have a functional 
effect using SIFT42. We found that, overall, the specialist and gener-
alist sublineages showed similar proportions of fixed substitutions 
(among all substitutions) predicted to affect gene function 23 (23.0% 
versus 20.6%; χ2 test, P = 0.62; Supplementary Table 6), suggesting 
that the mutational load of the ancestor populations did not differ 
significantly between generalists and specialists.
Small populations with restricted geographical ranges are expected 
to have reduced levels of genetic diversity43. Thus, one possible 
restriction to niche expansion by specialist sublineages could be that 
these sublineages have low genetic diversity, precluding adaptation 
to new hosts. We characterized the genetic diversity associated with 
the process of diversification in lineage 4 generalists and specialists, 
focusing on L4.3/LAM and L4.6.1/Uganda, which globally were the 
most frequent generalist and specialist sublineages of lineage 4 in 
our data set, respectively (Fig. 1b). We analyzed the whole-genome 
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Figure 2 Global distribution of lineage 4 sublineages. Pie charts show the proportions of the ten lineage 4 sublineages among all MTBC lineage 4 isolates  
in each country. Circle sizes correspond to the number of isolates analyzed per country. A total of 3,366 MTBC lineage 4 isolates were included.  
Color codes are as in Figure 1.
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sequences of 293 L4.3/LAM clinical strains representing the global 
diversity of this sublineage. These were selected from a global col-
lection of 2,132 L4.3/LAM isolates on the basis of standard genotyp-
ing data (Supplementary Figs. 7–9 and Supplementary Table 7). 
For L4.6.1/Uganda, we analyzed whole-genome sequences of 203 
clinical strains from Uganda and several neighboring countries 
(Supplementary Figs. 10 and 11, and Supplementary Table 7). This 
sample included 28 L4.6.1/Uganda strains identified through screen-
ing of 13,067 publically available MTBC whole-genome sequences 
(Online Methods)44–56. Comparing the genetic diversity of these 
two bacterial populations showed that L4.3/LAM was significantly 
more diverse than L4.6.1/Uganda (mean of 395 SNPs between pairs of 
isolates compared to 215 SNPs, respectively; Wilcoxon rank-sum 
test, P < 0.0001), consistent with the expected difference between 
generalists and specialists43.
Antigenic diversity in lineage 4 sublineages
We previously reported that, in the human-adapted MTBC, experi-
mentally confirmed human T cell epitopes were conserved57,58. This 
scenario is unlike that in many other pathogens where genomic regions 
encoding antigens tend to be diverse as a result of antigenic varia-
tion linked to immune escape59. When we assessed the evolutionary 
a b
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Figure 3 Country-specific proportions of sublineages identify generalists and specialists. (a) The generalist sublineages L4.1.2/Haarlem, L4.3/LAM  
and L4.10/PGG3 were found globally at high proportions. (b) The locally restricted specialist sublineages L4.1.3/Ghana, L4.5, L4.6.1/Uganda and 
L4.6.2/Cameroon occurred at high frequencies in only a few countries and were restricted to certain geographical regions. Intensity of red corresponds 
to the proportion of a sublineage among all lineage 4 isolates in each country. Countries with fewer than three isolates in total are shown as having ‘no 
data’ and are filled white. A total of 3,366 lineage 4 isolates were included in this analysis. The color scale for all sublineages is as indicated in a, 
except for sublineage L4.1.3/Ghana (separate scale shown).
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conservation of 1,226 experimentally confirmed human T cell epitopes60 
in L4.6.1/Uganda by calculating their ratios of nonsynonymous to 
synonymous substitutions (dN/dS), we found that these epitopes were 
significantly more conserved than the non-epitope regions of the corre-
sponding T cell antigens (Wilcoxon rank-sum test, P < 0.0001; Fig. 4). 
This result is consistent with our previous findings for the MTBC 
overall57,58. However, for the generalist L4.3/LAM sublineage, we saw 
the opposite: T cell epitopes showed significantly higher dN/dS ratios 
than non-epitope regions (Wilcoxon rank-sum test, P < 0.0001; Fig. 4). 
To test whether a high dN/dS ratio in genomic regions encoding T 
cell epitopes is characteristic of the generalist sublineages, we ana-
lyzed the genomes of 228 L4.2/Haarlem strains and 301 L4.10/PGG3 
strains identified by screening of 13,067 publically available genomes 
(Supplementary Figs. 12 and 13, and Supplementary Table 7). We 
found that, in contrast to L4.3/LAM, the epitope regions in these 
generalist sublineages were more conserved than the corresponding 
non-epitope regions, that is, similar to L4.6.1/Uganda and the MTBC 
overall57,58 (Fig. 4). Consistent with previous reports57,58,61, essential 
genes62 were significantly more conserved than nonessential genes in 
all sublineages, except L4.3/LAM, in which the dN/dS ratios of essen-
tial and nonessential genes were not significantly different (Fig. 4).
One of the limitations of our dN/dS analyses was that, despite 
a large number of genomes analyzed, within individual subline-
ages, the mean number of pairwise differences in regions encoding 
T cell epitopes was very small (Supplementary Table 8), limiting 
the accuracy of dN/dS inferences for epitopes. Hence, we assessed T 
cell epitope diversity by comparing the number of epitopes affected 
by nonsynonymous variants in the different sublineages (Fig. 5). 
We found that, in all four sublineages, the majority of epitopes were 
completely conserved, consistent with our previous findings for the 
MTBC overall57,58. However, each of the three generalist sublineages 
showed significantly more epitopes harboring at least one amino acid 
change when compared to the specialist sublineage L4.6.1/Uganda 
(χ2 test, P < 0.0001 for all comparisons; Fig. 5). It is possible that 
this comparably higher epitope diversity in generalists might reflect 
interactions with broader host populations.
The epitopes interrogated in our analysis were encoded by a total 
of 304 antigens. The number of antigens containing nonsynonymous 
variation in epitopes was 60, 26, 46 and 48 antigens in L4.3/LAM, 
L4.6.1/Uganda, L4.2/Haarlem and L4.10/PGG3, respectively. When 
excluding nonsynonymous mutations present only in one strain in 
each sublineage (which likely represent transient mutations), the 
number of antigens dropped to 20, 11, 12 and 24 in L4.3/LAM, L4.6.1/
Uganda, L4.2/Haarlem and L4.10/PGG3, respectively (Supplementary 
Table 9). Interestingly, ten of these antigens exhibited independent, 
parallel nonsynonymous variation in epitope regions in the differ-
ent sublineages (Supplementary Table 9). Of these antigens, Pst1, 
an adhesin promoting phagocytosis63, and FbpB, the precursor of 
the secreted antigen 85-B64, had already been identified as encod-
ing diverse epitopes by a previous study in which several MTBC 
lineages were compared57 (Supplementary Table 9). Other antigens 
exhibiting parallel nonsynonymous changes by different sublineages 
included known immunodominant secreted antigens such as Mpb64 
(ref. 64), MPT32 (ref. 65) and MPT70 (ref. 66) and three latency-
associated antigens (Rv1733c67, Rv3034c and Rv2628 (ref. 68); 
Supplementary Table 9).
Origin and global spread of the L4./LAM sublineage
Irrespective of the putative biological differences between the line-
age 4 sublineages, human migration could also have led to variation 
in the global distribution of MTBC lineages. Because the most suc-
cessful sublineage of lineage 4 was also frequently found in Europe, 
we hypothesized that the global success of L4.3/LAM was driven by 
European migration and colonization. To test this hypothesis, we first 
determined the most likely geographical origin of the most recent com-
mon ancestor of L4.3/LAM using two methods for reconstruction of 
ancestral states69. By both methods, Europe was predicted as the most 
likely place of origin for L4.3/LAM (prediction of 100% and 99.6% 
for each method, respectively) (Fig. 6a and Supplementary Fig. 14). 
Moreover, the ancestral geographical regions reconstructed for sub-
sequent nodes in the phylogeny were consistent with the spread of 
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Figure 5 Frequency distribution of the number of epitopes with 
nonsynonymous variants in generalist and specialist sublineages. A total 
of 1,226 T cell epitopes were included in the analysis. The number above 
each bar corresponds to the epitope count. The generalist sublineages are 
L4.3/LAM, L4.1.2/Haarlem and L4.10/PGG3, while L4.6.1/Uganda is  
a specialist sublineage. Statistical tests: L4.6.1/Uganda vs. L4.3/LAM,  
χ2 = 27.04, P < 0.001; L4.6.1/Uganda vs. L4.1.2/Haarlem, χ2 = 15.75, 
P < 0.001; L4.6.1/Uganda vs. L4.1.2/PGG3, χ2 = 68.24, P < 0.001.
Figure 4 Pairwise ratios of rates of nonsynonymous to synonymous 
substitutions (dN/dS) in generalist and specialist sublineages for  
different gene categories. Epi, experimentally confirmed human T cell 
epitopes; nEpi, non-epitope regions of T cell antigens (both obtained 
from the Immune Epitope Database60); Ess, essential genes62; nEss, 
nonessential genes62. Wilcoxon rank-sum tests: L4.6.1/Uganda (n = 203)  
Epi vs. nEpi, W = 4,952, P < 0.001; L4.6.1/Uganda (n = 203) Ess vs. 
nEss, W = 1,415, P < 0.001; L4.3/LAM (n = 293) Epi vs. nEpi,  
W = 74,540, P < 0.001; L4.3/LAM (n = 293) Ess vs. nEss, W = 45,067, 
P = 0.29; L4.1.2/Haarlem (n = 228) Epi vs. nEpi, W = 6,561, P < 0.001; 
L4.1.2/Haarlem (n = 228) Ess vs. nEss, W = 13,369, P < 0.001;  
L4.10/PGG3 (n = 301) Epi vs. nEpi, W = 27,335, P < 0.001;  
L4.10/PGG3 (n = 301) Ess vs. nEss, W = 3,103, P < 0.001.
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L4.3/LAM from Europe to other parts of the world (Fig. 6a). Finally, 
we found that L4.3/LAM strains from Europe were genetically more 
diverse than L4.3/LAM strains from other continents, which further 
supports a European origin for this sublineage (Kruskall–Wallis test, 
P < 0.0001; Fig. 6b,c).
DISCUSSION
Our findings show that the global success of lineage 4 is a consequence 
of both biological and social phenomena. Specifically, we found 
that lineage 4 is genetically diverse and that this diversity is 
phylogeographically structured. The phylogeography of lineage 4 
supports an ecological distinction between globally represented 
generalists and geographically restricted specialists. Our in-depth 
population genomic analyses of one specialist and three generalist 
sublineages showed that, even though the majority of human T cell 
epitopes were completely conserved in all four sublineages, the pro-
portion of epitopes with amino acid substitutions was significantly 
higher in generalists. Finally, we demonstrate a likely European 
origin for L4.1/LAM, the most frequent and globally widespread 
generalist sublineage of lineage 4.
Our observation that lineage 4 is phylogenetically diverse is in line 
with previous findings27,70 and highlights the importance of large and 
globally representative samples when studying the population struc-
ture of human pathogens. We found that lineage 4 comprises at least ten 
sublineages, which differ in their geographical distribution. The phy-
logeography of these sublineages is consistent with an ecological sepa-
ration into specialists and generalists, with some sublineages showing 
an intermediate geographical distribution. Our phylogenetic analyses 
also showed that the three generalist sublineages identified within 
lineage 4 were not monophyletic (Fig. 1a), indicating that generalism 
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Figure 6 Genome-based phylogeny and diversity by continent of 293 strains of the L4.3/LAM sublineage. (a) Bayesian phylogeny with label colors 
indicating continent of strain origin: blue, Europe/Mediterranean; red, sub-Saharan Africa; yellow, Americas; pink, Asia. Numbers on nodes indicate 
posterior probabilities. Pie charts show reconstructed ancestral geographical regions for the internal nodes. The pie colors correspond to the colors of 
the taxa labels. The hypothetical L4.3/LAM ancestor is labeled; a European origin for this ancestor was supported using a Bayesian method (shown) 
and a maximum-parsimony method (supplementary Fig. 14). The scale bar indicates nucleotide substitutions per site. (b) Box plots of pairwise genetic 
distances (number of polymorphisms) for L4.3/LAM strains by continent (P values are from Wilcoxon rank-sum tests). Each box corresponds to the 25% 
and 75% quantiles, the black line represents the median and the whiskers extend to 1.5 times the interquartile range. (c) Nucleotide diversity per site 
(π), measured by continent. Error bars indicate 95% confidence intervals. MTBC isolates from countries of the continent group “Oceania” (UN category; 
including Australia, New Zealand, Melanesia, Micronesia and Polynesia) were excluded from the genetic diversity analysis in b and c because of the  
low number of samples.
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was acquired multiple times independently during the evolution of 
lineage 4. Specialist sublineages also emerged multiple times, consist-
ent with local adaptation to separate human populations13.
One could argue that the reason for specialist sublineages being 
geographically restricted is that they diverged later than the generalist 
sublineages during the evolution of lineage 4 and thus had insufficient 
time to spread globally. However, on the basis of recent findings by 
Comas et al.71, the African specialist sublineages already existed at least 
several centuries ago, perhaps even several millennia ago, depending 
on the age of the most recent common ancestor of the MTBC, which 
has been estimated to be between 70,000 years9,21 and 6,000 years72,73. 
Thus, this timespan should have offered ample opportunity for the 
specialist sublineages to become more geographically widespread.
The genetic diversity of the specialist sublineage L4.6.1/Uganda was 
significantly lower than that of the generalist sublineage L4.3/LAM, 
as expected for populations with restricted geographical ranges43. 
Concomitantly, the diversity of T cell epitopes in the specialist sublin-
eage L4.6.1/Uganda was also significantly lower than that in any of the 
three generalist sublineages analyzed. Whether the low genetic diversity 
of the specialist sublineage has hindered the adaptation of these strains 
to other human populations or reflects a restricted niche due to lack of 
opportunity for spreading will need to be explored in future studies.
In all sublineages analyzed, the large majority of T cell epitopes 
were completely conserved, in agreement with previous reports for 
the MTBC overall57,58. This suggests that both generalists and special-
ists do not use antigenic variation as a main mechanism of immune 
evasion. Despite this general trend, we found that some antigens have 
acquired nonsynonymous mutations in parallel in the different sub-
lineages, suggesting that variation in these particular antigens might 
be beneficial. For example, acquiring nonsynonymous variation may 
allow particular antigens to be recognized by T cell receptors of dif-
ferent human populations, which might be beneficial in the presence 
of different human leukocyte antigen (HLA) alleles58. This could also 
provide an explanation for the differences in the degree of variation 
in T cell epitopes between the generalist and specialist sublineages, as 
generalist sublineages are expected to interact with a broader range 
of HLA alleles. Alternatively, some nonsynonymous mutations in 
epitopes might reflect escape from human T cell recognition58. More 
work is needed to determine whether and how the limited diversity in 
T cell epitopes in the MTBC is linked to adaptation to different host 
populations and/or immune escape.
Two independent phylogeographical analyses predicted Europe 
as the most likely geographical origin for the most recent common 
ancestor of the L4.3/LAM sublineage. A European origin for L4.3/
LAM was further supported by our finding that strains belonging 
to this sublineage were more genetically diverse in Europe than in 
Africa, Asia and the Americas. Taken together, these results suggest a 
role for Europeans in the spread of L4.3/LAM across the globe. Given 
the high frequency of L4.3/LAM in Europe (Figs. 2 and 3a)—particu-
larly in patients with tuberculosis from the Iberian Peninsula—and 
in Latin America74,75, Portuguese and Spanish exploration, trade and 
conquest over the last centuries may have contributed to the global 
dissemination of this sublineage76.
Of note, the Americas lack specialist sublineages, including the 
three African specialist sublineages, despite centuries of slave trade. 
Notably, this also applies to MTBC lineages 5 and 6 (M. africanum), 
which today are largely limited to parts of West Africa11, the source of 
most of the African slaves shipped to the Americas. Even if these line-
ages did reach the Americas at the time, they might have been replaced 
later by generalist sublineages from Europe, including L4.3/LAM, 
following the massive influx of Europeans to the Americas during the 
nineteenth and early twentieth centuries77, a time when the European 
tuberculosis epidemic was at its peak73,78. Notably, these human 
migrations can be viewed as natural experiments in which diverse 
human populations came into contact with different MTBC geno-
types. As mentioned above, there is evidence that the African spe-
cialist sublineages of lineage 4 already existed in sub-Saharan Africa 
centuries ago71. Following European contact, generalist sublineages 
were introduced to Africa, and, today, a significant proportion of 
human tuberculosis in Africa is caused by L4.1/LAM and other gen-
eralist sublineages (Figs. 2 and 3a). By contrast, hardly any spillover 
of African specialist sublineages has occurred into Europe or popula-
tions in the Americas of European ancestry.
Three of the ten sublineages showed an intermediate pattern of geo-
graphical distribution. Independent of the open question of whether 
they might represent generalists or specialists, it is interesting to note 
that none of these three sublineages were found at high frequency and 
proportion in Europe. They might therefore represent generalists of 
non-European origin. Deeper analyses are needed to shed more light 
on these sublineages.
Our study is limited in that many of the MTBC isolates analyzed 
come from convenient samples and might therefore not be representa-
tive of a particular country. However, for the analysis of sublineage 
distributions by SNP genotyping, we included more than 3,000 clinical 
isolates from 100 countries, which should help reduce potential selec-
tion bias. For the deep genomic analyses, we selected strains on the 
basis of a large and diverse collection of classical genotyping patterns 
and, in addition, screened >13,000 MTBC whole-genome sequences 
available in public repositories. As a further limitation, some isolates 
in our collection were obtained from patients who recently emigrated 
from a region of high tuberculosis incidence into a country with low 
incidence. However, we excluded cases from ongoing transmission 
and focused on immigrants with reactivation disease: these individu-
als were most likely infected in their country of origin before moving 
abroad. Moreover, we used country of birth for all analyses as opposed 
to country of tuberculosis diagnosis.
In conclusion, our findings indicate that the global success of line-
age 4 partly results from the different evolutionary strategies adopted 
by different sublineages. These strategies reflect an ecological distinc-
tion between specialists and generalists. The specialist sublineages 
are adapted to their sympatric host populations and are geographi-
cally restricted. The generalist sublineages exhibit a broader ecologi-
cal niche and are geographically widespread. Moreover, Europeans 
contributed to the global spread of the most successful generalist 
sublineage of lineage 4. Our results highlight the ecological and epi-
demiological relevance of the deep phylogenetic diversity within the 
MTBC79. More generally, exploring potential differences between spe-
cialists and generalists in other pathogens will improve understanding 
of the biology and epidemiology of infectious diseases.
URLs. Immune Epitope Database and Analysis Resource, http://www.
iedb.org/; United Nations macro-geographical regions, http://unstats.
un.org/unsd/methods/m49/m49regin.htm; DWA-GIS, http://www.
diva-gis.org/Data; sciCORE, http://scicore.unibas.ch/; Mesquite, 
http://mesquiteproject.org/.
METHODS
Methods, including statements of data availability and any associated 
accession codes and references, are available in the online version of 
the paper.
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Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
ACKNOWLEDGMENTS
We thank S. Lecher, S. Li and J. Zallet for technical support. Calculations were 
performed at the sciCORE scientific computing core facility at the University  
of Basel. This work was supported by the Swiss National Science Foundation 
(grants 310030_166687 (S.G.) and 320030_153442 (M.E.) and Swiss HIV Cohort 
Study grant 740 to L.F.), the European Research Council (309540-EVODRTB  
to S.G.), TB-PAN-NET (FP7-223681 to S.N.), PathoNgenTrace projects  
(FP7-278864-2 to S.N.), SystemsX.ch (S.G.), the German Center for Infection Research 
(DZIF; S.N.), the Novartis Foundation (S.G.), the Natural Science Foundation of 
China (91631301 to Q.G.), and the National Institute of Allergy and Infectious 
Diseases (5U01-AI069924-05) of the US National Institutes of Health (M.E.).
AUTHOR CONTRIBUTIONS
D.S., D. Brites, L.J., S.N. and S.G. planned the experiments. D.S., L.J., D. Brites, A.T., 
L.F., L.R., S.B., M. Ballif, Q.L., T.L., Q.G., M.K.-M., M. Bonnet, M.E., R.M., H.M., 
M.M., G.T.V., J.F., M.G., J.T., F.J., J.L.G., A.A.-P., D.Y.-M., E.W., W.S., M.J., W.H.B., 
I.B., J.B., M.S., S.E.G.V., P. Suffys, A.K., R.W., L.G.-B., B.M., S.D.L., H.-P.B., B.C.d.J., 
K.T., E.S.-P., M. Bonnet, A.G.-B., M.F., V.N.P.B., K.E., I.A., P.W.N., G.R., F.G.,  
S. Akter, F.N., L.S.-I., N.E.N., A.R., M.H., D.M.C., G.S., S.H., D. Bakonyte, P. 
Stakenas, R.D., V.C., O.M., S. Al-Hajoj, L.O., F.B., E.J.C., L.D., P. Supply and I.C. 
contributed reagents and performed the experiments. D.S., L.J., D. Brites, M.C., 
S.N. and S.G. analyzed the data. D.S., L.J., D. Brites, S.N. and S.G. wrote the 
manuscript. All authors critically reviewed the manuscript. 
COMPETING FINANCIAL INTERESTS
The authors declare no competing financial interests.
Reprints and permissions information is available online at http://www.nature.com/
reprints/index.html.
1. Futuyma, D.J. & Moreno, G. The evolution of ecological specialization. Annu. Rev. 
Ecol. Syst. 19, 207–233 (1988).
2. Woolhouse, M.E., Webster, J.P., Domingo, E., Charlesworth, B. & Levin, B.R. 
Biological and biomedical implications of the co-evolution of pathogens and their 
hosts. Nat. Genet. 32, 569–577 (2002).
3. Woolhouse, M.E., Taylor, L.H. & Haydon, D.T. Population biology of multihost 
pathogens. Science 292, 1109–1112 (2001).
4. Kirzinger, M.W. & Stavrinides, J. Host specificity determinants as a genetic 
continuum. Trends Microbiol. 20, 88–93 (2012).
5. Vouga, M. & Greub, G. Emerging bacterial pathogens: the past and beyond. 
Clin. Microbiol. Infect. 22, 12–21 (2016).
6. Brites, D. & Gagneux, S. Co-evolution of Mycobacterium tuberculosis and Homo 
sapiens. Immunol. Rev. 264, 6–24 (2015).
7. Borrell, S. & Gagneux, S. Infectiousness, reproductive fitness and evolution 
of drug-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 13, 
1456–1466 (2009).
8. Merker, M. et al. Evolutionary history and global spread of the Mycobacterium 
tuberculosis Beijing lineage. Nat. Genet. 47, 242–249 (2015).
9. Luo, T. et al. Southern East Asian origin and coexpansion of Mycobacterium 
tuberculosis Beijing family with Han Chinese. Proc. Natl. Acad. Sci. USA 112, 
8136–8141 (2015).
10. Cowley, D. et al. Recent and rapid emergence of W-Beijing strains of Mycobacterium 
tuberculosis in Cape Town, South Africa. Clin. Infect. Dis. 47, 1252–1259 
(2008).
11. de Jong, B.C., Antonio, M. & Gagneux, S. Mycobacterium africanum—review of an 
important cause of human tuberculosis in West Africa. PLoS Negl. Trop. Dis. 4, 
e744 (2010).
12. Firdessa, R. et al. Mycobacterial lineages causing pulmonary and extrapulmonary 
tuberculosis, Ethiopia. Emerg. Infect. Dis. 19, 460–463 (2013).
13. Gagneux, S. Host–pathogen coevolution in human tuberculosis. Phil. Trans. R. Soc. 
Lond. B 367, 850–859 (2012).
14. Fenner, L. et al. HIV infection disrupts the sympatric host–pathogen relationship 
in human tuberculosis. PLoS Genet. 9, e1003318 (2013).
15. Gagneux, S. et al. Variable host–pathogen compatibility in Mycobacterium 
tuberculosis. Proc. Natl. Acad. Sci. USA 103, 2869–2873 (2006).
16. Baker, L., Brown, T., Maiden, M.C. & Drobniewski, F. Silent nucleotide polymorphisms 
and a phylogeny for Mycobacterium tuberculosis. Emerg. Infect. Dis. 10, 
1568–1577 (2004).
17. Reed, M.B. et al. Major Mycobacterium tuberculosis lineages associate with patient 
country of origin. J. Clin. Microbiol. 47, 1119–1128 (2009).
18. Demay, C. et al. SITVITWEB—a publicly available international multimarker 
database for studying Mycobacterium tuberculosis genetic diversity and molecular 
epidemiology. Infect. Genet. Evol. 12, 755–766 (2012).
19. Coscolla, M. & Gagneux, S. Consequences of genomic diversity in Mycobacterium 
tuberculosis. Semin. Immunol. 26, 431–444 (2014).
20. Coscolla, M. & Gagneux, S. Does M. tuberculosis genomic diversity explain disease 
diversity? Drug Discov. Today Dis. Mech. 7, e43–e59 (2010).
21. Comas, I. et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium 
tuberculosis with modern humans. Nat. Genet. 45, 1176–1182 (2013).
22. Coscolla, M. et al. Novel Mycobacterium tuberculosis complex isolate from a wild 
chimpanzee. Emerg. Infect. Dis. 19, 969–976 (2013).
23. Abadia, E. et al. Resolving lineage assignation on Mycobacterium tuberculosis 
clinical isolates classified by spoligotyping with a new high-throughput 3R SNPs 
based method. Infect. Genet. Evol. 10, 1066–1074 (2010).
24. Filliol, I. et al. Global phylogeny of Mycobacterium tuberculosis based on single 
nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, 
phylogenetic accuracy of other DNA fingerprinting systems, and recommendations 
for a minimal standard SNP set. J. Bacteriol. 188, 759–772 (2006).
25. Sreevatsan, S. et al. Restricted structural gene polymorphism in the Mycobacterium 
tuberculosis complex indicates evolutionarily recent global dissemination. 
Proc. Natl. Acad. Sci. USA 94, 9869–9874 (1997).
26. Homolka, S. et al. High resolution discrimination of clinical Mycobacterium 
tuberculosis complex strains based on single nucleotide polymorphisms. PLoS One 
7, e39855 (2012).
27. Coll, F. et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex 
strains. Nat. Commun. 5, 4812 (2014).
28. Tsolaki, A.G. et al. Functional and evolutionary genomics of Mycobacterium 
tuberculosis: insights from genomic deletions in 100 strains. Proc. Natl. Acad. Sci. 
USA 101, 4865–4870 (2004).
29. Comas, I., Homolka, S., Niemann, S. & Gagneux, S. Genotyping of genetically 
monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights 
the limitations of current methodologies. PLoS One 4, e7815 (2009).
30. Yeboah-Manu, D. et al. Genotypic diversity and drug susceptibility patterns among 
M. tuberculosis complex isolates from South-Western Ghana. PLoS One 6, e21906 
(2011).
31. Malla, B. et al. First insights into the phylogenetic diversity of Mycobacterium 
tuberculosis in Nepal. PLoS One 7, e52297 (2012).
32. Fenner, L. et al. Mycobacterium tuberculosis transmission in a country with low 
tuberculosis incidence: role of immigration and HIV infection. J. Clin. Microbiol. 
50, 388–395 (2012).
33. Ballif, M. et al. Genetic diversity of Mycobacterium tuberculosis in Madang, Papua 
New Guinea. Int. J. Tuberc. Lung Dis. 16, 1100–1107 (2012).
34. Wampande, E.M. et al. Long-term dominance of Mycobacterium tuberculosis 
Uganda family in peri-urban Kampala-Uganda is not associated with cavitary 
disease. BMC Infect. Dis. 13, 484 (2013).
35. Ley, S.D. et al. Diversity of Mycobacterium tuberculosis and drug resistance in 
different provinces of Papua New Guinea. BMC Microbiol. 14, 307 (2014).
36. Stucki, D. et al. Two new rapid SNP-typing methods for classifying Mycobacterium 
tuberculosis complex into the main phylogenetic lineages. PLoS One 7, e41253 
(2012).
37. Bouakaze, C. et al. Matrix-assisted laser desorption ionization–time of flight mass 
spectrometry–based single nucleotide polymorphism genotyping assay using iPLEX 
gold technology for identification of Mycobacterium tuberculosis complex species 
and lineages. J. Clin. Microbiol. 49, 3292–3299 (2011).
38. World Health Organization. Global Tuberculosis Control—Surveillance, Planning, 
Financing (WHO, 2015).
39. Möller, M., de Wit, E. & Hoal, E.G. Past, present and future directions in human 
genetic susceptibility to tuberculosis. FEMS Immunol. Med. Microbiol. 58, 3–26 
(2010).
40. Caws, M. et al. The influence of host and bacterial genotype on the development 
of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 4, 
e1000034 (2008).
41. Asante-Poku, A. et al. Mycobacterium africanum is associated with patient ethnicity 
in Ghana. PLoS Negl. Trop. Dis. 9, e3370 (2015).
42. Ng, P.C. & Henikoff, S. SIFT: predicting amino acid changes that affect protein 
function. Nucleic Acids Res. 31, 3812–3814 (2003).
43. Ellstrand, N.C. & Elam, D.R. Population genetic consequences of small population size: 
implications for plant conservation. Annu. Rev. Ecol. Syst. 24, 217–242 (1993).
44. Lanzas, F., Karakousis, P.C., Sacchettini, J.C. & Ioerger, T.R. Multidrug-resistant 
tuberculosis in Panama is driven by clonal expansion of a multidrug-resistant 
Mycobacterium tuberculosis strain related to the KZN extensively drug-resistant 
M. tuberculosis strain from South Africa. J. Clin. Microbiol. 51, 3277–3285 (2013).
45. Bryant, J.M. et al. Inferring patient to patient transmission of Mycobacterium 
tuberculosis from whole genome sequencing data. BMC Infect. Dis. 13, 110 
(2013).
46. Bryant, J.M. et al. Whole-genome sequencing to establish relapse or re-infection 
with Mycobacterium tuberculosis: a retrospective observational study. Lancet Respir. 
Med. 1, 786–792 (2013).
47. Gardy, J.L. et al. Whole-genome sequencing and social-network analysis of a 
tuberculosis outbreak. N. Engl. J. Med. 364, 730–739 (2011).
48. Casali, N. et al. Evolution and transmission of drug-resistant tuberculosis in a 
Russian population. Nat. Genet. 46, 279–286 (2014).
49. Walker, T.M. et al. Whole-genome sequencing to delineate Mycobacterium 
tuberculosis outbreaks: a retrospective observational study. Lancet Infect. Dis. 13, 
137–146 (2013).
50. Roetzer, A. et al. Whole genome sequencing versus traditional genotyping for 
investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular 
epidemiological study. PLoS Med. 10, e1001387 (2013).
© 
20
16
 N
at
u
re
 A
m
er
ic
a,
 In
c.
, p
ar
t 
o
f 
S
p
ri
n
g
er
 N
at
u
re
. A
ll 
ri
g
h
ts
 r
es
er
ve
d
.
Nature GeNetics  ADVANCE ONLINE PUBLICATION 
A rt i c l e s
51. Farhat, M.R. et al. Genomic analysis identifies targets of convergent positive 
selection in drug-resistant Mycobacterium tuberculosis. Nat. Genet. 45, 
1183–1189 (2013).
52. Clark, T.G. et al. Elucidating emergence and transmission of multidrug-resistant 
tuberculosis in treatment experienced patients by whole genome sequencing. 
PLoS One 8, e83012 (2013).
53. Jamieson, F.B. et al. Whole-genome sequencing of the Mycobacterium tuberculosis 
Manila sublineage results in less clustering and better resolution than mycobacterial 
interspersed repetitive-unit-variable-number tandem-repeat (MIRU-VNTR) typing 
and spoligotyping. J. Clin. Microbiol. 52, 3795–3798 (2014).
54. Pérez-Lago, L. et al. Whole genome sequencing analysis of intrapatient microevolution 
in Mycobacterium tuberculosis: potential impact on the inference of tuberculosis 
transmission. J. Infect. Dis. 209, 98–108 (2014).
55. Guerra-Assunção, J.A. et al. Recurrence due to relapse or reinfection with 
Mycobacterium tuberculosis: a whole-genome sequencing approach in a large, 
population-based cohort with a high HIV infection prevalence and active follow-up. 
J. Infect. Dis. 211, 1154–1163 (2015).
56. Guerra-Assunção, J.A. et al. Large-scale whole genome sequencing of M. tuberculosis 
provides insights into transmission in a high prevalence area. eLife 4, e05166 
(2015).
57. Comas, I. et al. Human T cell epitopes of Mycobacterium tuberculosis are 
evolutionarily hyperconserved. Nat. Genet. 42, 498–503 (2010).
58. Coscolla, M. et al. M. tuberculosis T cell epitope analysis reveals paucity of antigenic 
variation and identifies rare variable TB antigens. Cell Host Microbe 18, 538–548 
(2015).
59. Deitsch, K.W., Lukehart, S.A. & Stringer, J.R. Common strategies for antigenic 
variation by bacterial, fungal and protozoan pathogens. Nat. Rev. Microbiol. 7, 
493–503 (2009).
60. Ernst, J.D. et al. Meeting Report: NIH Workshop on the Tuberculosis Immune 
Epitope Database. Tuberculosis (Edinb.) 88, 366–370 (2008).
61. Pepperell, C.S. et al. The role of selection in shaping diversity of natural 
M. tuberculosis populations. PLoS Pathog. 9, e1003543 (2013).
62. Zhang, Y.J. et al. Global assessment of genomic regions required for growth in 
Mycobacterium tuberculosis. PLoS Pathog. 8, e1002946 (2012).
63. Esparza, M. et al. PstS-1, the 38-kDa Mycobacterium tuberculosis glycoprotein, is 
an adhesin, which binds the macrophage mannose receptor and promotes 
phagocytosis. Scand. J. Immunol. 81, 46–55 (2015).
64. Bekmurzayeva, A., Sypabekova, M. & Kanayeva, D. Tuberculosis diagnosis using 
immunodominant, secreted antigens of Mycobacterium tuberculosis. Tuberculosis 
(Edinb.) 93, 381–388 (2013).
65. Nagai, S., Wiker, H.G., Harboe, M. & Kinomoto, M. Isolation and partial 
characterization of major protein antigens in the culture fluid of Mycobacterium 
tuberculosis. Infect. Immun. 59, 372–382 (1991).
66. Juárez, M.D., Torres, A. & Espitia, C. Characterization of the Mycobacterium 
tuberculosis region containing the mpt83 and mpt70 genes. FEMS Microbiol. Lett. 
203, 95–102 (2001).
67. Coppola, M. et al. Synthetic long peptide derived from Mycobacterium tuberculosis 
latency antigen Rv1733c protects against tuberculosis. Clin. Vaccine Immunol. 22, 
1060–1069 (2015).
68. Araujo, L.S. et al. Profile of interferon-γ response to latency-associated and novel 
in vivo expressed antigens in a cohort of subjects recently exposed to Mycobacterium 
tuberculosis. Tuberculosis (Edinb.) 95, 751–757 (2015).
69. Yu, Y., Harris, A.J., Blair, C. & He, X. RASP (Reconstruct Ancestral State in Phylogenies): 
a tool for historical biogeography. Mol. Phylogenet. Evol. 87, 46–49 (2015).
70. Brudey, K. et al. Mycobacterium tuberculosis complex genetic diversity: mining the 
fourth international spoligotyping database (SpolDB4) for classification, population 
genetics and epidemiology. BMC Microbiol. 6, 23 (2006).
71. Comas, I. et al. Population genomics of Mycobacterium tuberculosis in Ethiopia 
contradicts the virgin soil hypothesis for human tuberculosis in sub-Saharan Africa. 
Curr. Biol. 25, 3260–3266 (2015).
72. Bos, K.I. et al. Pre-Columbian mycobacterial genomes reveal seals as a source of 
New World human tuberculosis. Nature 514, 494–497 (2014).
73. Kay, G.L. et al. Eighteenth-century genomes show that mixed infections were 
common at time of peak tuberculosis in Europe. Nat. Commun. 6, 6717 (2015).
74. Lazzarini, L.C. et al. Discovery of a novel Mycobacterium tuberculosis lineage that 
is a major cause of tuberculosis in Rio de Janeiro, Brazil. J. Clin. Microbiol. 45, 
3891–3902 (2007).
75. Perdigão, J. et al. Unraveling Mycobacterium tuberculosis genomic diversity and 
evolution in Lisbon, Portugal, a highly drug resistant setting. BMC Genomics 15, 
991 (2014).
76. Mokrousov, I. et al. Latin-American–Mediterranean lineage of Mycobacterium 
tuberculosis: human traces across pathogen’s phylogeography. Mol. Phylogenet. 
Evol. 99, 133–143 (2016).
77. Baily, S.L. & Miguez, E.J. Mass Migration to Modern Latin America.  (Scholarly 
Resources,1993).
78. Bates, J.H. & Stead, W.W. The history of tuberculosis as a global epidemic. 
Med. Clin. North Am. 77, 1205–1217 (1993).
79. Gagneux, S. & Small, P.M. Global phylogeography of Mycobacterium tuberculosis 
and implications for tuberculosis product development. Lancet Infect. Dis. 7, 
328–337 (2007).
1Swiss Tropical and Public Health Institute, Basel, Switzerland. 2University of Basel, Basel, Switzerland. 3Forschungszentrum Borstel, Borstel, Germany.  
4Institut Pasteur de Tunis, Université de Tunis El Manar, Tunis, Tunisia. 5Key Laboratory of Medical Molecular Virology of the Ministries of Education and Health, 
Institutes of Biomedical Sciences and Institute of Medical Microbiology, School of Basic Medical Sciences, Fudan University, Shanghai, China. 6Institute for Social 
and Preventive Medicine, University of Bern, Bern, Switzerland. 7Laboratory of Infection and Immunity, School of Basic Medical Science, West China Center of 
Medical Sciences, Sichuan University, Chengdu, China. 8School of Medicine, University of California at San Francisco, San Francisco, California, USA. 9Laboratório 
de Saúde Pública, Lisbon, Portugal. 10Hospital Nossa Senhora da Paz, Cubal, Angola. 11Servei de Microbiologia, Hospital Clínic–ISGlobal, Barcelona, Spain.  
12Victorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia. 13Ifakara Health Institute, Bagamoyo, Tanzania. 14Public Health Ontario, Toronto, 
Ontario, Canada. 15Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana. 16Department of Medical Microbiology, Makerere University, 
Kampala, Uganda. 17Department of Global Health, University of Amsterdam, Amsterdam, the Netherlands. 18Department of Molecular Biology and Microbiology, Case 
Western Reserve University, Cleveland, Ohio, USA. 19LabPlus, Auckland City Hospital, Auckland, New Zealand. 20Life and Health Sciences Research Institute (ICVS), 
School of Health Sciences, University of Minho, Braga, Portugal. 21ICVS/3B’s—PT Government Associate Laboratory, Braga/Guimarães, Portugal. 22Oswaldo Cruz 
Institute, Rio de Janeiro, Brazil. 23Institute of Infectious Disease and Molecular Medicine, and Department of Clinical Laboratory Sciences, University of Cape Town, 
Cape Town, South Africa. 24Department of Medicine, Imperial College London, London, UK. 25Francis Crick Institute Mill Hill Laboratory, London, UK. 26Papua New 
Guinea Institute of Medical Research, Goroka, Papua New Guinea. 27Insitute of Tropical Medicine, Antwerp, Belgium. 28Tartu University Hospital United Laboratories, 
Mycobacteriology, Tartu, Estonia. 29Clinical Research Department, Epicentre, Paris, France. 30Department of Microbiology, University Hospital La Fe, Valencia, Spain. 
31Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany. 32Institute Laboratory for Tuberculosis Research (LTR), Biotechnology Center (BTC), 
University of Yaoundé I, Yaoundé, Cameroon. 33Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. 34Department  
of Medical Laboratory Technology, Faculty of Medical Technology, Baghdad, Iraq. 35Institute of Tropical Medicine and Infectious Diseases (ITROMID), Jomo  
Kenyatta University of Agriculture and Technology (JKUAT), Nairobi, Kenya. 36Department of Pathology, Aga Khan University Hospital (AKUH), Nairobi, Kenya.  
37Medical Research Council, Fajara, the Gambia. 38Fondation Congolaise pour la Recherche Médicale, Université Marien Gouabi, Brazzaville, Republic of the Congo. 
39Right to Care and the Clinical HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa. 40National Institute of Medical Research, Mbeya 
Medical Research Centre (NIMR-MMRC), Mbeya, Tanzania. 41Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich, and 
German Centre for Infection Research (DZIF), partner site Munich, Munich, Germany. 42Emerging Bacterial Pathogens Unit, IRCCS, San Raffaele Scientific Institute, 
Milan, Italy. 43Riga East University Hospital, Centre of Tuberculosis and Lung Diseases, Riga, Latvia. 44WHO Supranational TB Reference Laboratory, Department  
of Microbiology, Public Health Agency of Sweden, Solna, Sweden. 45Department of Immunology and Cell Biology, Institute of Biotechnology, Vilnius University,  
Vilnius, Lithuania. 46Institute for Epidemiology, Schleswig-Holstein University Hospital, Kiel, Germany. 47National Tuberculosis Reference Laboratory, Phthysiopneumology 
Institute, Chisinau, Moldova. 48‘Marius Nasta’ Pneumophtisiology Institute, Bucharest, Romania. 49Department of Infection and Immunity, King Faisal Specialist Hospital 
and Research Centre, Riyadh, Saudi Arabia. 50Instituto de Medicina Tropical Alexander von Humboldt, Molecular Epidemiology Unit–Tuberculosis, Universidad 
Peruana Cayetano Heredia, Lima, Peru. 51Warren Alpert School of Medicine at Brown University, Miriam Hospital, Providence, Rhode Island, USA. 52Moi University 
School of Medicine, Eldoret, Kenya. 53Université Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, CIIL, Centre d’Infection et 
d’Immunité de Lille, Lille, France. 54Institute of Biomedicine of Valencia (IBV-CSIC), Valencia, Spain. 55CIBER Epidemiology and Public Health, Madrid, Spain. 
56German Center for Infection Research, Borstel Site, Borstel, Germany. 57These authors contributed equally to this work. Correspondence  
should be addressed to S.G. (sebastien.gagneux@unibas.ch).
© 
20
16
 N
at
u
re
 A
m
er
ic
a,
 In
c.
, p
ar
t 
o
f 
S
p
ri
n
g
er
 N
at
u
re
. A
ll 
ri
g
h
ts
 r
es
er
ve
d
.
Nature GeNetics doi:10.1038/ng.3704
ONLINE METHODS
Mycobacterial isolates. For the definition of lineage 4 sublineages, we used 72 
whole-genome sequences of MTBC lineage 4 and reference sequences for the 
other MTBC lineages published previously21,22 (Supplementary Table 7). These 
represented the largest collection of lineage 4 whole-genome sequences avail-
able at that time. For SNP screening of clinical isolates for sublineage classifica-
tion, we used a retrospective global collection of 3,366 MTBC lineage 4 isolates 
from 100 countries (Supplementary Table 5)15,30–35. All isolates had previously 
been identified as MTBC lineage 4 by SNP typing, genomic deletion analysis 
or spoligotyping. Approximately one-third of these isolates were from patients 
who migrated to another country (1,106; 32.9%), and we used country of birth 
for each patient as a proxy for the origin of the MTBC strains. Two-thirds of the 
isolates (2,260; 67.1%) were from patients for whom the country of isolation and 
country of birth were the same. Isolates of L4.6.1/Uganda from Uganda were 
genotyped in our previous work34. For the in-depth population genomic analysis 
of L4.3/LAM, we included previously published genomes21,27,44 and generated 
whole-genome sequences of additional strains selected from a large collection of 
2,132 MIRU-VNTR-genotyped isolates representing the global diversity of L4.3/
LAM (Supplementary Fig. 7). Starting from 500 whole-genome sequences, we 
excluded sequences with bad quality (sequencing coverage <15× or proportion 
of homozygous variant calls <85%), isolates in transmission clusters (defined as 
isolate pairs differing by ≤12 SNPs) and strains with unknown country of origin, 
resulting in whole-genome sequencing data for 293 L4.3/LAM strains, which 
were included in the final analysis (Supplementary Table 7). For the in-depth 
population genomic analyses of L4.6.1/Uganda, we generated whole-genome 
sequencing data for 175 isolates of the L4.6.1/Uganda genotype, selected for 
maximal geographical diversity and from previous studies34. Moreover, to fur-
ther increase geographical coverage and genetic diversity among L4.6.1/Uganda 
strains, we analyzed all available whole-genome sequencing data from several 
published studies8,45–56,75 and other whole-genome data available in the pub-
lic domain. We used KvarQ80 to screen for the L4.6.1/Uganda-specific SNPs 
described below. Starting from 13,067 genome sequences and excluding all 
clustered isolates except for one representative of each cluster, we identified 28 
additional L4.6.1/Uganda genome sequences that we included in our analysis 
of a total of 203 genomes (Supplementary Table 7). For genomic analysis of 
L4.1.2/Haarlem and L4.10/PGG3 strains, we screened the same 13,067 isolates 
(plus our own collection) for clade-specific SNPs for these two sublineages. We 
identified 505 genome sequences for L4.1.2/Haarlem and 748 sequences for 
L4.10/PGG3. After excluding problematic sequences and strains in transmis-
sion clusters (for criteria, see above), we used 228 strains from L4.1.2/Haarlem 
and 301 strains from L4.10/PGG3. H37Rv was used as the outgroup for all 
sublineage phylogenies except that for L4.10/PGG3, for which an isolate from 
L4.1.2/Haarlem was used (H37Rv belongs to L4.10/PGG3).
Whole-genome sequencing, variant calling and filtering. Whole-genome 
sequencing of new MTBC isolates was performed using Illumina chemistry 
(MiSeq, HiSeq 2000/2500, NextSeq; paired end or single end). Illumina MiSeq-
generated sequencing reads were clipped for adaptors with Trimmomatic81 
before mapping. We used a previously described pipeline for the mapping of 
short sequencing reads to the reference genome (a reconstructed hypothetical 
MTBC ancestor) with BWA 0.6.2 (ref. 21). SNPs were called with SAMtools 
0.1.19 and excluded if the coverage was less than 10% or more than 200% of the 
average coverage for the genome, if not supported by at least two reads on each 
strand or if the quality was less than 30. All SNPs were then annotated using 
H37Rv reference annotation (AL123456.2) with ANNOVAR82 and customized 
scripts. SNPs in regions annotated as ‘PE/PPE/PGRS’, ‘maturase’, ‘phage’ or 
‘insertion sequence’ were excluded. Additionally, we excluded SNPs in genes 
with previously identified repetitive regions58. Small insertions and deletions 
called by BWA/SAMtools as ‘INDEL’ were not considered for the analyses. The 
presence of large genomic deletions reported previously15,28,74 was assessed 
by manually inspecting BAM alignment files from BWA mappings in Artemis 
for the presence of reads in the genomic regions with described deletions. 
Alternatively, we used a new test suite in KvarQ80 to check for reads aligning 
to 25-bp query sequences of the corresponding deletion.
Phylogenetic and population genetic analyses for the definition of 
sublineages. A phylogenetic tree was generated with all lineage 4 genomes, 
plus several reference genomes from all other MTBC lineages. Pairwise 
SNP distances were calculated using MEGA5 (ref. 83) and the ape package 
in R (ref. 84). FST values (estimation of population separation) were calculated 
using Arlequin 3.5 (ref. 85). Statistical significance was obtained by permu-
tating haplotypes between sublineages. Principal-component analysis was 
carried out with Jalview86. Naming of the lineage 4 sublineages was adapted 
to that of Coll et al.27 whenever possible. However, in that publication, no 
criteria for the definition of sublineages were given and not all sublineages 
were identified as such. We therefore added continuous numbers for the clades 
that were not defined by Coll et al. The new sublineages defined in this study 
are L4.1.3/Ghana and L4.10/PGG3 (with the latter including L4.5, L4.8 and 
L4.9 according to the nomenclature from Coll et al.). The full phylogenetic 
tree, including previous markers and spoligotyping family names, is shown 
in Supplementary Figure 1.
Identification of sublineage-specific SNPs. The alignment of all SNPs from 
the initial 72 MTBC lineage 4 strains was imported into Mesquite, in parallel 
with the phylogenetic tree generated from the same data in MEGA5. We used 
the ‘Trace Character History’ module of Mesquite to map polymorphisms to 
clades. The full data set of reconstructed positions was exported, and subline-
age-specific SNPs were extracted as nucleotide differences between internal 
nodes of the phylogeny.
SNP typing to screen for MTBC lineage 4 sublineages. We developed 
a new SNP typing assay to screen clinical isolates for the defined lineage 4 
sublineages. For this, we selected one ‘diagnostic’ SNP per sublineage using 
previously defined methods and criteria36. Oligonucleotides were designed 
for a 10-plex MOL-PCR assay based on the Luminex xTag platform (Luminex) 
(Supplementary Table 2)36. DNA extracts from clinical MTBC isolates 
were then screened with (i) the new MOL-PCR assay, (ii) standard PCR 
amplification and subsequent Sanger sequencing of the region up- and 
downstream of the sublineage-specific SNP (see Supplementary Table 4  
for PCR and sequencing primers), (iii) a real-time PCR melting curve assay 
using the same SNPs (Supplementary Table 2), or (iv) the MassARRAY 
platform (Sequenom) using phylogenetically redundant SNPs (Supplementary 
Table 3). The set of SNPs used in the MassARRAY typing scheme covered 
only six of the ten sublineages. Hence, all lineage 4 isolates for which none 
of the six SNPs in the MassARRAY typing had the mutant allele (n = 49) 
were subjected to the Luminex assay described above. For all isolates, patient 
place of birth was used as country information. We obtained sublineage 
classification data for 3,273 (97.2%) of a total of 3,366 isolates (Supplementary 
Table 5).
Spatial analysis and data presentation. For each country with lineage 4 sub-
lineage data available, sublineage proportions (in comparison to all lineage 4 
isolates from the same country) were calculated and mapped to a world map 
with ArcGIS ArcMap 10.0 (Esri). A shapefile with country boundaries was used 
from DIVA-GIS, which is freely available. Categories for number of countries 
were defined as 0, 1–3, 4–10 and >10 countries. For individual sublineage 
‘heat maps’, countries with fewer than three isolates were not included. For the 
additional maps shown in Supplementary Figure 6, sublineage proportions 
were normalized by the tuberculosis prevalence in the country, as estimated 
by the World Health Organization (WHO)38, and the area of the country. 
Other figures were generated with the ggplot2 library in R and with GraphPad 
Prism 6.02 (GraphPad Software). Statistical analyses were performed with 
R or GraphPad Prism.
SIFT analyses of the functional effects of fixed sublineage-specific SNPs. 
SNPs fixed in each of the ten sublineages were assessed for predicted functional 
consequence with SIFT in the software SIFT4G (v2.1)42 and the precompiled 
M. tuberculosis database GCA_000195955.2.22. Conservation levels of SNPs 
in the precompiled database had been obtained by comparing M. tuberculosis 
H37Rv proteins to all proteins in the UniRef87 database. We pooled SNPs 
fixed in the generalist sublineages and the specialist sublineages separately and 
excluded the L4.1.2/Ghana sublineage, as whole-genome sequences for only 
two very closely related isolates were available. Gene categories were analyzed 
on the basis of the classification by Tuberculist88.
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Phylogenetic reconstruction and population genetic analyses. The final 
alignment of polymorphic positions in all strains was used to estimate phy-
logenies with Bayesian methods using MrBayes 3.2.5 (ref. 89) for the L4.3/
LAM and L4.6.1/Uganda sublineages (Fig. 6 and Supplementary Fig. 10). For 
the Bayesian analysis, we used a gamma rate distribution estimated from our 
data set and a burn-in equal to one-tenth the number of generations; after the 
burn-in phase, every 100th tree was saved. Two parallel Markov chains were 
run in each of two runs. The tree length, log-likelihood score and alpha value 
of the gamma distribution were inspected for stationarity before termination 
of MrBayes. Trees were generated with standard parameters. A consensus 
tree was used for further analyses. Additionally, we used MEGA5 (ref. 83) 
to generate maximum-likelihood phylogenetic trees (Supplementary Figs. 9 
and 11–13). We used the general time-reversible (GTR) model of evolution 
and 500 pseudoreplicates for bootstrapping confidence levels. Positions with 
gaps in more than 50% of the taxa were ignored. Tree figures were generated 
using FigTree version 1.4.2. Pairwise SNP distances were calculated with the 
ape package and the dna.dist function in R version 3.2.2, using raw counts of 
mutations and pairwise deletions for sites with gaps. For the comparison of 
pairwise number-of-SNP distributions overall (L4.3/LAM and L4.6.1/Uganda) 
and between continents for L4.3/LAM, a mean SNP distance to all isolates of 
the same population was calculated for each isolate and a distribution of the 
mean pairwise distance was plotted. Wilcoxon rank-sum and Kruskall–Wallis 
tests were used to test for differences between continents, as data were assumed 
not to be normally distributed. Average pairwise nucleotide diversities per site 
(π) were calculated as the average number of pairwise mismatches among a set 
of sequences divided by the total length of the interrogated sequences in base 
pairs (equation (4).21 in ref. 87). Confidence intervals for π were obtained 
through bootstrapping (1,000 replicates) by resampling with replacement the 
nucleotide sites of the original alignments of polymorphic positions using the 
function sample in R. Lower and upper levels of confidence were obtained by 
calculating the 2.5th and 97.5th quantiles of the π distribution obtained by 
bootstrapping. Code details are available upon request.
Antigenic diversity in human T cell epitopes. Experimentally confirmed 
human MTBC T cell epitope sequences were retrieved from the Immune 
Epitope Database on 24 April 2015. Only linear epitopes from the MTBC 
(77643) tested in human T cell assays, with no major histocompatibility com-
plex (MHC) restrictions, were selected (1,730 epitopes). The sequence of 
each epitope was searched by BLASTP90 against the reference strain (H37Rv) 
to obtain genomic coordinates. Epitopes with no coordinates in H37Rv or 
for which no accurate coordinates could be determined (owing to multiple 
hits) and epitopes in repetitive regions such as PE/PPE genes, phage-related 
genes and transposases were excluded, rendering a final set of 1,226 epitopes. 
These epitopes are distributed across 304 antigens and have some overlapping 
sequences. To proceed with the sequence analysis, alignments were obtained 
by concatenating all epitope sequences after excluding sequence redundancy. 
Alignments of non-epitope-containing antigens were obtained by excluding 
the regions described as epitopes for each respective antigen. To assess how 
other regions of the genome are evolving, alignments for essential and non-
essential genes were also obtained62.
Alignments of epitopes and non-epitope-containing regions for antigens, as 
well as essential and nonessential genes, were used to calculate pairwise dN/dS 
ratios for the L4.3/LAM, L4.6.1/Uganda, L4.10/PGG3 and L4.1.2/Haarlem 
sublineages. The dN/dS measures were calculated using all polymorphic sites 
within each sublineage and therefore reflect both within-sublineage substitu-
tions and transient polymorphisms. Pairwise dN and dS values within each 
sublineage were calculated using the R package seqinr with the kaks function. 
To avoid having undetermined pairwise dN/dS values due to dN or dS being 
zero, a mean dN/dS value was then calculated for each sequenced isolate by 
dividing its mean pairwise dN by its mean pairwise dS with respect to all other 
sequenced isolates within each sublineage. The statistical differences between 
the epitopes and non-epitope regions of antigens within each sublineage were 
accessed using Wilcoxon rank-sum tests with continuity correction imple-
mented in R version 3.2.2.
Reconstruction of the geographical origin of L4.3/LAM. The software 
RASP69 was used to reconstruct the hypothetical geographical origin of the 
MTBC L4.3/LAM ancestor genotype. The Bayesian phylogeny of 294 isolates 
(including H37Rv as the outgroup) and the corresponding continents of birth 
for patients were loaded as a distribution. We used the S-DIVA (a parsimony-
based method) as well as the Bayesian binary method (BBM) implementation 
in RASP. A set of trees from MrBayes89 was used to correct for phylogenetic 
uncertainty in the S-DIVA analysis. Populations were defined according to 
country of birth of the patients and according to United Nations definition. 
The isolates from Turkey, Libya, Algeria and Morocco were in the category 
‘Europe and Mediterranean’. RASP reconstruction was performed without 
the outgroup (H37Rv). As we observed a single strain (from Ukraine) with 
a distinct, basal position in the phylogeny, we also performed a sensitivity 
analysis by excluding that isolate for the RASP analysis. With both methods, 
BBM as well as S-DIVA, the changes in the proportion of strains from each 
continent were minor. With BBM, the proportion of ‘Europe/Mediterranean’ 
for the ‘L4.3/LAM ancestor’ decreased to 98.8%, and with S-DIVA the 
proportion of ‘Europe/Mediterranean’ decreased to 99.0% when excluding 
this basal isolate.
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